Cambridge scientists have uncovered compelling evidence that the food you consume can influence cancer’s growth and spread. Research published in the journal Nature highlights the impact of the dietary nutrient asparagine on breast tumors.
Found in foods such as asparagus, poultry, and seafood, asparagine appears to play a crucial role in tumor proliferation. This discovery opens new avenues for cancer treatment, targeting cancer’s “culinary addictions.”
Table of contents
The Role of Asparagine
Asparagine is an amino acid, essential for protein synthesis, named after asparagus, a primary source. The study conducted by the Cancer Research UK Cambridge Institute focused on mice with aggressive breast cancer. Typically, these mice succumb to the disease within weeks as the tumors metastasize throughout their bodies. However, a significant change occurred when the mice were fed a low-asparagine diet or given drugs to block asparagine. The tumors struggled to spread, and cancerous cells became difficult to detect.
Significant Findings
Professor Greg Hannon, who led the study, described the results as a “huge change.” The tumors, which usually spread rapidly, were significantly stunted. This breakthrough follows previous research by the University of Glasgow, which showed that removing amino acids serine and glycine slowed lymphoma and intestinal cancer development.
The Mechanism of Spread
An initial tumor rarely proves fatal. It becomes life-threatening when cancer cells metastasize, spreading throughout the body. For a cancer cell to spread, it must detach from the primary tumor, survive in the bloodstream, and thrive in a new location. Researchers believe asparagine is crucial for this process.
Implications for Human Treatment
While these findings are promising, they are based on animal models. The next step is to confirm whether reducing asparagine intake can have similar effects in humans. As asparagine is prevalent in many foods, avoiding it completely is challenging. However, future treatments may involve special nutritionally balanced drinks that lack asparagine.
Existing Treatments and Future Possibilities
Interestingly, the drug L-asparaginase, which targets asparagine, is already used to treat acute lymphoblastic leukemia. Professor Charles Swanton, Cancer Research UK’s chief clinician, suggests that this drug could potentially be repurposed to treat breast cancer. However, further trials are necessary to validate this approach.
Expert Opinions and Cautions
Baroness Delyth Morgan, chief executive at Breast Cancer Now, advises patients against drastic dietary changes based on this study alone. She emphasizes consulting healthcare providers before excluding any specific food group. Additionally, she encourages a healthy and varied diet for all patients.
Conclusion
This groundbreaking research underscores the potential of dietary modifications in cancer treatment. By targeting specific nutrients like asparagine, scientists hope to develop new strategies to combat cancer. However, it is essential to approach these findings cautiously and await further trials to confirm their applicability to human patients. As research progresses, the hope is that such dietary interventions could significantly improve cancer therapy outcomes.